Cronos (CRON) Gains from Investment Securities (2019 - 2026)
Cronos (CRON) recorded quarterly Gains from Investment Securities of $1.5 million in Q1 2026, up 130.12% quarter-over-quarter from -$5.1 million in Q4 2025, and down 47.51% on a YoY basis from $2.9 million in Q1 2025.
Cronos (CRON) Gains from Investment Securities (2019 - 2026) Analysis & Trends
Cronos' Gains from Investment Securities history runs 8 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 47.51% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at -$3.6 million (up 63.6% YoY), while the FY2023 annual figure was $23.3 million, down 61.97% from the prior year.
- Gains from Investment Securities was $1.5 million for Q1 2026 at Cronos, up from -$5.1 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $32.5 million in Q3 2024 to a low of -$58.1 million in Q4 2024.
- Historically, Gains from Investment Securities has averaged $7.1 million across 5 years, with a median of $12.0 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities soared 10701.89% in 2022, then tumbled 348.9% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $21.2 million in 2022, then increased by 10.24% to $23.3 million in 2023, then sank by 348.9% to -$58.1 million in 2024, then surged by 91.21% to -$5.1 million in 2025, then soared by 130.12% to $1.5 million in 2026.
- The last three Gains from Investment Securities figures came in at $1.5 million (Q1 2026), -$5.1 million (Q4 2025), and $2.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | -5.11 Mn |
| Dec 31, 2025 | -5.11 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | -58.12 Mn |
| Dec 31, 2024 | -58.12 Mn |
| Sep 30, 2024 | 32.47 Mn |
| Sep 30, 2024 | 32.47 Mn |
| Jun 30, 2024 | 12.92 Mn |
| Jun 30, 2024 | 12.92 Mn |
| Mar 31, 2024 | 12.73 Mn |
| Mar 31, 2024 | 12.73 Mn |
| Dec 31, 2023 | 23.35 Mn |
| Dec 31, 2023 | 23.35 Mn |
| Mar 31, 2023 | 743,000.00 |
| Mar 31, 2023 | 743,000.00 |
| Dec 31, 2022 | 21.18 Mn |
| Dec 31, 2022 | 21.18 Mn |